Data search
Results for MligTC455_35373
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_35373 | 50 | 1.03 | Mlig455_065912, Mlig455_070019 | Neo: - Age: Down-Up-Down Regeneration-upregulated BL: 7.651 Regeneration-enriched BL: 7.651 |
GLRA2 | Mlig455_065912 {REF} {Length: 3290} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=157.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=121.2]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=327, Expect=1e-106]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=321, Expect=2e-104]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=319, Expect=1e-103]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=325, Expect=4e-106]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=323, Expect=3e-105]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=317, Expect=3e-103]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=313, Expect=2e-101]} {Dmel: FBgn0024963, GluClalpha, [Score=291, Expect=5e-93]} {Celegans: WBGene00001587, ggr-2, GABA/Glycine Receptor family (See gbr), [RH, Score=249, Expect=2e-76]} {Smed: dd_Smed_v6_15331_0_1, dd_Smed_v6_15331_0_1, [Score=283, Expect=3e-90]} {RNA1509_32923} {RNA1310_14629.1} {RNA815_27491} Mlig455_070019 {REF} {Length: 4890} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=157.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=120.3]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=326, Expect=2e-106]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=323, Expect=4e-105]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=318, Expect=2e-103]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=325, Expect=5e-106]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=324, Expect=7e-106]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=317, Expect=6e-103]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=313, Expect=1e-101]} {Dmel: FBgn0024963, GluClalpha, [Score=288, Expect=7e-92]} {Celegans: WBGene00001587, ggr-2, GABA/Glycine Receptor family (See gbr), [RH, Score=249, Expect=2e-76]} {Smed: dd_Smed_v6_15331_0_1, dd_Smed_v6_15331_0_1, [Score=284, Expect=2e-90]} {RNA1509_32923} {RNA1310_14629.1} {RNA815_27491} |
Cumulative graph for MligTC455_35373
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | -0.042 | 1.212 | 0.99989 | 1.00000 | |
| RegionR2 | 2.868 | 1.212 | 0.17116 | 0.51747 | |
| RegionR3 | 2.09 | 1.212 | 0.13572 | 0.63050 | |
| RegionR4 | 1.76 | 1.212 | 0.32311 | 0.64056 | |
| RegionR5 | -0.438 | 1.212 | 0.68632 | 1.00000 | |
| RegionR6 | -2.828 | 1.212 | 0.99963 | 1.00000 | |
| RegionR7 | -1.636 | 1.212 | 0.99990 | 1.00000 | |
| RegionR8 | -1.774 | 1.212 | 0.99987 | 1.00000 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | 0.426 | 1.212 | 0.99993 | 1.00000 | |
| RegenerationR2 | 2.094 | 1.212 | 0.08049 | 0.45680 | |
| RegenerationR3 | 0.65 | 1.212 | 0.65628 | 0.93158 | |
| RegenerationR4 | -0.658 | 1.212 | 0.74733 | 0.96971 | |
| RegenerationR5 | 0.675 | 1.212 | 0.68517 | 0.94558 | |
| RegenerationR6 | 3.3 | 1.212 | 0.16461 | 0.49445 | |
| RegenerationBL | 7.651 | 1.212 | 0.00010 | 0.00439 | Specific for BL: 7.651 |
| RegenerationTP | 3.156 | 1.212 | 0.29709 | 0.74256 |
Genes with expression patterns similar to MligTC455_35373
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_35373 | 50 | 1.03 | Mlig455_065912, Mlig455_070019 | Neo: - Age: Down-Up-Down Regeneration-upregulated BL: 7.651 Regeneration-enriched BL: 7.651 |
GLRA2 | 5 | 1.000 | 1.000 | - | 1.000 | 1.000 | 1.000 | Mlig455_065912 {REF} {Length: 3290} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=157.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=121.2]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=327, Expect=1e-106]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=321, Expect=2e-104]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=319, Expect=1e-103]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=325, Expect=4e-106]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=323, Expect=3e-105]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=317, Expect=3e-103]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=313, Expect=2e-101]} {Dmel: FBgn0024963, GluClalpha, [Score=291, Expect=5e-93]} {Celegans: WBGene00001587, ggr-2, GABA/Glycine Receptor family (See gbr), [RH, Score=249, Expect=2e-76]} {Smed: dd_Smed_v6_15331_0_1, dd_Smed_v6_15331_0_1, [Score=283, Expect=3e-90]} {RNA1509_32923} {RNA1310_14629.1} {RNA815_27491} Mlig455_070019 {REF} {Length: 4890} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=157.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=120.3]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=326, Expect=2e-106]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=323, Expect=4e-105]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=318, Expect=2e-103]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=325, Expect=5e-106]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=324, Expect=7e-106]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=317, Expect=6e-103]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=313, Expect=1e-101]} {Dmel: FBgn0024963, GluClalpha, [Score=288, Expect=7e-92]} {Celegans: WBGene00001587, ggr-2, GABA/Glycine Receptor family (See gbr), [RH, Score=249, Expect=2e-76]} {Smed: dd_Smed_v6_15331_0_1, dd_Smed_v6_15331_0_1, [Score=284, Expect=2e-90]} {RNA1509_32923} {RNA1310_14629.1} {RNA815_27491} |
| 2. | MligTC455_30159 | 107 | 2.22 | Mlig455_008465, Mlig455_009916 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.961/0.00498 |
TCF7L1 | 2.771 | 0.916 | - | - | 0.960 | - | 0.895 | Mlig455_008465 {REF} {Length: 2454} {Pfam: HMG (high mobility group) box [PF00505.21, score=81.3]; HMG-box domain [PF09011.12, score=34.6]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=7e-43]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=3e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=156, Expect=8e-42]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=161, Expect=4e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=4e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=6e-43]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=157, Expect=4e-41]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=2e-48]} {RNA1310_11181} {RNA815_36690} Mlig455_009916 {REF} {Length: 2137} {Pfam: HMG (high mobility group) box [PF00505.21, score=81.4]; HMG-box domain [PF09011.12, score=34.7]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=4e-43]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=2e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=157, Expect=5e-42]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=162, Expect=2e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=3e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=4e-43]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=157, Expect=3e-41]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=1e-48]} {RNA1310_11181} {RNA815_36690} |
| 3. | MligTC455_47393 | 241 | 5.03 | Mlig455_008718, Mlig455_063579 | Neo: - Age: Down-Up-Down Region-enriched R2: 3.683/0.00849 |
CALM2 | 2.686 | 0.950 | - | - | 0.837 | - | 0.899 | Mlig455_008718 {REF} {Length: 1727} {Pfam: EF hand [PF00036.34, score=99.3]; EF-hand domain pair [PF13499.8, score=95.1]; EF-hand domain [PF13405.8, score=86.1]; EF-hand domain pair [PF13833.8, score=76.8]; EF hand [PF13202.8, score=75.3]; EF-hand domain [PF14658.8, score=46.0]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=27.9]; EF-hand domain [PF08976.13, score=23.4]; Uncharacterised protein family (UPF0154) [PF03672.15, score=18.7]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=108, Expect=4e-30]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=4e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=4e-30]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-30]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=108, Expect=2e-30]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=1e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-30]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-30]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=114, Expect=8e-33]} {RNA1310_33847.1} {RNA815_17211} Mlig455_063579 {REF} {Length: 2562} {Pfam: EF hand [PF00036.34, score=95.8]; EF-hand domain pair [PF13499.8, score=92.8]; EF-hand domain [PF13405.8, score=82.9]; EF-hand domain pair [PF13833.8, score=74.4]; EF hand [PF13202.8, score=72.2]; EF-hand domain [PF14658.8, score=43.8]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=25.6]; EF-hand domain [PF08976.13, score=21.4]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=111, Expect=7e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=3e-29]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=3e-29]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=111, Expect=7e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-29]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-29]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=9e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-29]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-29]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=111, Expect=9e-31]} {RNA1310_12431.1} {RNA815_17211} |
| 4. | MligTC455_43650 | 38 | 0.8 | Mlig455_053802, Mlig455_068539 | Neo: - Age: - Region-enriched R4: 4.824/0.02628 |
2.637 | - | - | - | 0.966 | 0.822 | 0.849 | Mlig455_053802 {REF} {Length: 1475} {Pfam: Activin types I and II receptor domain [PF01064.25, score=23.1]} {RNA1310_88727} Mlig455_068539 {REF} {Length: 1648} {Pfam: Activin types I and II receptor domain [PF01064.25, score=21.6]} {RNA1310_88727} |
|
| 5. | MligTC455_40687 | 28 | 0.58 | Mlig455_040563, Mlig455_062078 | Neo: - Age: - |
PDE1C | 2.557 | 0.821 | - | - | 0.980 | - | 0.756 | Mlig455_040563 {REF} {Length: 1798} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.1]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.0]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=362, Expect=2e-117]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=358, Expect=2e-117]} {Mouse: ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=362, Expect=5e-118]; ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=362, Expect=7e-120]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=346, Expect=4e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_21546_0_1, dd_Smed_v6_21546_0_1, [Score=396, Expect=7e-133]} {RNA1310_80402} Mlig455_062078 {REF} {Length: 1807} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.6]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.1]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=356, Expect=3e-115]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=355, Expect=5e-116]} {Mouse: ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=359, Expect=1e-118]; ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=356, Expect=8e-116]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=347, Expect=2e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_26758_0_1, dd_Smed_v6_26758_0_1, [Score=394, Expect=3e-132]} {RNA1509_46211} {RNA1310_80402} {RNA815_55704} |
| 6. | MligTC455_12312 | 158 | 3.3 | Mlig455_020134, Mlig455_045030 | Neo: - Age: - |
SYT7 | 2.519 | 0.795 | - | - | 0.766 | - | 0.958 | Mlig455_020134 {REF} {Length: 2000} {Pfam: C2 domain [PF00168.32, score=69.8]} {Human: ENSG00000011347, SYT7, synaptotagmin 7, [Score=130, Expect=1e-31]} {Mouse: ENSMUSG00000024743, Syt7, synaptotagmin VII, [Score=119, Expect=2e-28]; ENSMUSG00000062542, Syt9, synaptotagmin IX, [Score=116, Expect=1e-27]; ENSMUSG00000026452, Syt2, synaptotagmin II, [Score=116, Expect=8e-28]} {Dmel: FBgn0261089, Sytalpha, Synaptotagmin alpha, [Score=157, Expect=5e-42]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=116, Expect=3e-28]} {Smed: dd_Smed_v6_4222_0_1, dd_Smed_v6_4222_0_1, [Score=115, Expect=2e-28]} {RNA1509_46689} {RNA1310_12025} {RNA815_31022} Mlig455_045030 {REF} {Length: 3640} {Pfam: C2 domain [PF00168.32, score=110.2]} {Human: ENSG00000011347, SYT7, synaptotagmin 7, [Score=169, Expect=6e-45]; ENSG00000143858, SYT2, synaptotagmin 2, [Score=164, Expect=9e-45]; ENSG00000170743, SYT9, synaptotagmin 9, [Score=163, Expect=6e-44]} {Mouse: ENSMUSG00000026452, Syt2, synaptotagmin II, [Score=164, Expect=7e-45]; ENSMUSG00000062542, Syt9, synaptotagmin IX, [Score=164, Expect=2e-44]; ENSMUSG00000024743, Syt7, synaptotagmin VII, [Score=158, Expect=9e-42]} {Dmel: FBgn0261089, Sytalpha, Synaptotagmin alpha, [RH, Score=202, Expect=2e-58]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=153, Expect=6e-41]} {Smed: dd_Smed_v6_4222_0_1, dd_Smed_v6_4222_0_1, [Score=160, Expect=5e-44]} {RNA1509_46689} {RNA1310_12025} {RNA815_31022} |
| 7. | MligTC455_29412 | 46 | 0.96 | Mlig455_000627, Mlig455_008268, Mlig455_040614 | Neo: - Age: Up-Down-Up |
2.448 | - | 0.702 | - | 0.959 | - | 0.787 | Mlig455_000627 {REF} {Length: 1331} {RNA1310_62571} {RNA815_30942} Mlig455_008268 {REF} {Length: 1779} {RNA1509_47298} {RNA1310_98344} {RNA815_10804.1} Mlig455_040614 {REF} {Length: 1016} |
|
| 8. | MligTC455_10299 | 72 | 1.51 | Mlig455_023028, Mlig455_023125, Mlig455_023183 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.617 Region-enriched R2: 4.572/0.04281 |
ANGPTL1 | 1.916 | - | - | - | 0.968 | 0.948 | - | Mlig455_023028 {REF} {Length: 2538} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=130.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=115, Expect=8e-29]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=112, Expect=1e-27]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=114, Expect=2e-28]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=112, Expect=9e-28]} {Dmel: FBgn0050280, CG30280, [Score=103, Expect=9e-26]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=50.8, Expect=4e-08]} {RNA1509_41017} {RNA1310_41391} {RNA815_23568} Mlig455_023125 {REF} {Length: 2398} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=127.5]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=112, Expect=2e-27]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=107, Expect=1e-25]} {Mouse: ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=107, Expect=7e-26]} {Dmel: FBgn0050280, CG30280, [Score=92.8, Expect=6e-22]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=51.2, Expect=3e-08]} {RNA1509_41017} {RNA1310_41391} {RNA815_23568} Mlig455_023183 {REF} {Length: 2190} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=129.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=115, Expect=2e-28]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=110, Expect=9e-27]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=113, Expect=4e-28]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=110, Expect=6e-27]} {Dmel: FBgn0003326, sca, scabrous, [Score=104, Expect=8e-25]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=50.4, Expect=4e-08]} {RNA1509_41017} {RNA1310_41391} {RNA815_23568} |
| 9. | MligTC455_16208 | 38 | 0.8 | Mlig455_060360 | Neo: - Age: - |
FCN2 | 1.899 | - | - | - | 0.963 | - | 0.936 | Mlig455_060360 {REF} {Length: 1127} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=136.3]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=118, Expect=7e-31]; ENSG00000085265, FCN1, ficolin 1, [Score=117, Expect=3e-30]} {Mouse: ENSMUSG00000026835, Fcnb, ficolin B, [Score=116, Expect=6e-30]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=111, Expect=5e-27]} {Dmel: FBgn0034160, CG5550, [Score=109, Expect=6e-28]} {Celegans: WBGene00020516, T15B7.1, [Score=52.4, Expect=1e-07]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=96.3, Expect=5e-22]} {RNA1310_68891} |
| 10. | MligTC455_20350 | 434 | 9.05 | Mlig455_002780, Mlig455_066934 | Neo: - Age: - Region-enriched R2: 3.513/0.00619 |
SYT12 | 1.886 | - | - | - | 0.927 | - | 0.959 | Mlig455_002780 {REF} {Length: 2380} {Pfam: C2 domain [PF00168.32, score=69.7]} {Human: ENSG00000173227, SYT12, synaptotagmin 12, [Score=214, Expect=3e-64]} {Mouse: ENSMUSG00000049303, Syt12, synaptotagmin XII, [Score=207, Expect=1e-61]} {Dmel: FBgn0261085, Syt12, Synaptotagmin 12, [Score=182, Expect=3e-50]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=142, Expect=2e-37]} {Smed: dd_Smed_v6_8032_0_1, dd_Smed_v6_8032_0_1, [Score=234, Expect=3e-72]} {RNA1310_10982.1} {RNA815_10652.1} Mlig455_066934 {REF} {Length: 2274} {Pfam: C2 domain [PF00168.32, score=69.7]} {Human: ENSG00000173227, SYT12, synaptotagmin 12, [Score=214, Expect=3e-64]} {Mouse: ENSMUSG00000049303, Syt12, synaptotagmin XII, [Score=206, Expect=1e-61]} {Dmel: FBgn0261085, Syt12, Synaptotagmin 12, [Score=182, Expect=3e-50]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=142, Expect=2e-37]} {Smed: dd_Smed_v6_8032_0_1, dd_Smed_v6_8032_0_1, [Score=234, Expect=2e-72]} {RNA1310_10982.1} {RNA815_10652.1} |
| 11. | MligTC455_33394 | 29 | 0.6 | Mlig455_020353, Mlig455_041292 | Neo: - Age: - |
RASGRP1, RASGRP3 | 1.884 | 0.917 | - | - | 0.967 | - | - | Mlig455_020353 {REF} {Length: 2230} {Pfam: RasGEF domain [PF00617.21, score=61.8]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=51.4]; EF hand [PF00036.34, score=33.2]; EF-hand domain [PF13405.8, score=32.5]; EF-hand domain pair [PF13499.8, score=28.5]; EF hand [PF13202.8, score=28.0]} {Human: ENSG00000152689, RASGRP3, RAS guanyl releasing protein 3, [Score=360, Expect=2e-115]; ENSG00000172575, RASGRP1, RAS guanyl releasing protein 1, [Score=349, Expect=6e-110]} {Mouse: ENSMUSG00000071042, Rasgrp3, RAS, guanyl releasing protein 3, [Score=356, Expect=2e-114]} {Dmel: FBgn0003093, Pkc98E, Protein C kinase 98E, [Score=65.1, Expect=9e-11]} {Celegans: WBGene00009100, rgef-1, Rap Guanine nucleotide Exchange Factor homolog, [Score=302, Expect=3e-94]} {Smed: dd_Smed_v6_15742_0_2, dd_Smed_v6_15742_0_2, [Score=270, Expect=3e-85]} {RNA1310_83329} Mlig455_041292 {REF} {Length: 3588} {Pfam: RasGEF domain [PF00617.21, score=145.2]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=52.4]; EF hand [PF00036.34, score=34.0]; EF-hand domain [PF13405.8, score=33.3]; EF-hand domain pair [PF13499.8, score=30.9]; EF hand [PF13202.8, score=29.5]; EF-hand domain pair [PF13833.8, score=19.2]} {Human: ENSG00000172575, RASGRP1, RAS guanyl releasing protein 1, [RH, Score=451, Expect=8e-148]} {Mouse: ENSMUSG00000071042, Rasgrp3, RAS, guanyl releasing protein 3, [RH, Score=453, Expect=2e-150]; ENSMUSG00000027347, Rasgrp1, RAS guanyl releasing protein 1, [RH, Score=438, Expect=3e-143]} {Dmel: FBgn0034158, CG5522, [Score=95.9, Expect=3e-20]} {Celegans: WBGene00009100, rgef-1, Rap Guanine nucleotide Exchange Factor homolog, [Score=416, Expect=2e-136]} {Smed: dd_Smed_v6_15742_0_2, dd_Smed_v6_15742_0_2, [RH, Score=288, Expect=3e-91]} {RNA1509_53196} {RNA1310_34349} {RNA815_31634} |
| 12. | MligTC455_24614 | 62 | 1.29 | Mlig455_015091, Mlig455_015206 | Neo: - Age: logFC(26M/2M)=-0.441 Region-enriched R4: 7.131/0.00032 Regeneration-downregulated R4: -4.923 Regeneration-depleted R4: -4.923 |
ECT2 | 1.883 | - | - | - | 0.932 | - | 0.951 | Mlig455_015091 {REF} {Length: 3092} {Pfam: RhoGEF domain [PF00621.22, score=124.1]; Domain of unknown function (DUF4795) [PF16043.7, score=21.0]; Winged helix-turn helix [PF13592.8, score=19.5]} {Human: ENSG00000114346, ECT2, epithelial cell transforming 2, [Score=78.6, Expect=2e-14]} {Mouse: ENSMUSG00000020640, Itsn2, intersectin 2, [Score=78.6, Expect=2e-14]; ENSMUSG00000027699, Ect2, ect2 oncogene, [Score=74.7, Expect=2e-13]} {Dmel: FBgn0003041, pbl, pebble, [Score=57.0, Expect=6e-08]} {Celegans: WBGene00002297, ect-2, ECT2 (Mammalian Rho GEF) homolog, [Score=67.0, Expect=3e-11]} {Smed: dd_Smed_v6_2922_0_1, dd_Smed_v6_2922_0_1, [Score=59.7, Expect=5e-09]} {RNA1509_21158} {RNA1310_6370} {RNA815_1845} Mlig455_015206 {REF} {Length: 3091} {Pfam: RhoGEF domain [PF00621.22, score=124.1]; Domain of unknown function (DUF4795) [PF16043.7, score=21.0]; Winged helix-turn helix [PF13592.8, score=19.5]} {Human: ENSG00000114346, ECT2, epithelial cell transforming 2, [Score=78.6, Expect=2e-14]} {Mouse: ENSMUSG00000020640, Itsn2, intersectin 2, [Score=78.6, Expect=2e-14]; ENSMUSG00000027699, Ect2, ect2 oncogene, [Score=74.7, Expect=2e-13]} {Dmel: FBgn0003041, pbl, pebble, [Score=57.0, Expect=6e-08]} {Celegans: WBGene00002297, ect-2, ECT2 (Mammalian Rho GEF) homolog, [Score=67.0, Expect=3e-11]} {Smed: dd_Smed_v6_2922_0_1, dd_Smed_v6_2922_0_1, [Score=59.7, Expect=5e-09]} {RNA1509_21158, RNA1509_7033} {RNA1310_6370, RNA1509_21158, RNA1509_7033} {RNA1509_21158, RNA1509_7033, RNA815_1845} |
| 13. | MligTC455_48064 | 23 | 0.48 | Mlig455_061550 | Neo: - Age: - |
1.874 | - | - | - | 0.953 | - | 0.921 | Mlig455_061550 {REF} {Length: 860} {RNA1310_88363} {RNA815_47885} | |
| 14. | MligTC455_48521 | 56 | 1.17 | Mlig455_004444 | Neo: - Age: - |
1.861 | - | - | - | 0.955 | - | 0.906 | Mlig455_004444 {REF} {Length: 3968} {Pfam: GDNF/GAS1 domain [PF02351.18, score=19.4]} {Smed: dd_Smed_v6_19517_0_1, dd_Smed_v6_19517_0_1, [RH, Score=111, Expect=3e-25]} {RNA1509_50708} {RNA1310_13399} {RNA815_27009} | |
| 15. | MligTC455_47420 | 218 | 4.54 | Mlig455_017159, Mlig455_048110 | Neo: - Age: - Region-specific R2: 6.469 Region-enriched R2: 5.851/0.00135 |
1.858 | - | - | - | 0.961 | - | 0.897 | Mlig455_017159 {REF} {Length: 1062} {RNA1509_35349} {RNA1310_81586} Mlig455_048110 {REF} {Length: 527} {RNA1310_81586} |
|
| 16. | MligTC455_50172 | 243 | 5.05 | Mlig455_067182 | Neo: - Age: Down-Up-Up Region-specific R2: 6.036 Region-enriched R2: 6.524/0.00000 |
1.853 | - | - | - | 0.903 | - | 0.950 | Mlig455_067182 {REF} {Length: 638} {Pfam: Pancreatic hormone peptide [PF00159.20, score=47.5]} {RNA1509_60030} {RNA1310_56761, RNA1509_60030} {RNA1509_60030, RNA815_31877.1} | |
| 17. | MligTC455_51806 | 83 | 1.73 | Mlig455_037702, Mlig455_046362 | Neo: - Age: - |
GPSM2 | 1.848 | - | - | - | 0.894 | - | 0.954 | Mlig455_037702 {REF} {Length: 3216} {Pfam: Tetratricopeptide repeat [PF13424.8, score=100.7]; Tetratricopeptide repeat [PF13176.8, score=98.7]; Tetratricopeptide repeat [PF00515.30, score=93.3]; GoLoco motif [PF02188.19, score=66.5]; Tetratricopeptide repeat [PF07719.19, score=54.7]; Tetratricopeptide repeat [PF13181.8, score=43.2]; Tetratricopeptide repeat [PF13374.8, score=34.5]; Rapsyn N-terminal myristoylation and linker region [PF10579.11, score=20.8]} {Human: ENSG00000121957, GPSM2, G protein signaling modulator 2, [RH, Score=521, Expect=3e-176]} {Mouse: ENSMUSG00000026930, Gpsm1, G-protein signalling modulator 1 (AGS3-like, C. elegans), [RH, Score=494, Expect=2e-166]} {Dmel: FBgn0040080, pins, partner of inscuteable, [RH, Score=534, Expect=0.0]} {Celegans: WBGene00000092, ags-3, Activator of G protein Signalling, [Score=256, Expect=4e-76]} {Smed: dd_Smed_v6_6548_1_1, dd_Smed_v6_6548_1_1, [RH, Score=462, Expect=3e-154]} {RNA1310_18538} {RNA815_41322} Mlig455_046362 {REF} {Length: 3324} {Pfam: Tetratricopeptide repeat [PF13424.8, score=119.4]; Tetratricopeptide repeat [PF13176.8, score=96.3]; Tetratricopeptide repeat [PF00515.30, score=93.0]; GoLoco motif [PF02188.19, score=85.6]; Tetratricopeptide repeat [PF07719.19, score=54.4]; Tetratricopeptide repeat [PF13181.8, score=42.7]; Tetratricopeptide repeat [PF13374.8, score=34.2]; Rapsyn N-terminal myristoylation and linker region [PF10579.11, score=21.7]} {Human: ENSG00000121957, GPSM2, G protein signaling modulator 2, [Score=545, Expect=0.0]} {Mouse: ENSMUSG00000027883, Gpsm2, G-protein signalling modulator 2 (AGS3-like, C. elegans), [RH, Score=535, Expect=0.0]} {Dmel: FBgn0040080, pins, partner of inscuteable, [RH, Score=531, Expect=1e-180]} {Celegans: WBGene00000092, ags-3, Activator of G protein Signalling, [RH, Score=266, Expect=1e-79]} {Smed: dd_Smed_v6_6548_1_1, dd_Smed_v6_6548_1_1, [RH, Score=474, Expect=1e-158]} {RNA1310_18538} {RNA815_41322} |
| 18. | MligTC455_27216 | 56 | 1.18 | Mlig455_022418 | Neo: - |
TRPM3 | 1.847 | - | - | - | 0.959 | - | 0.888 | Mlig455_022418 {REF} {Length: 4794} {Pfam: SLOG in TRPM [PF18139.3, score=136.8]; Ion transport protein [PF00520.33, score=41.0]; SLOG in TRPM, prokaryote [PF18171.3, score=34.2]} {Human: ENSG00000083067, TRPM3, transient receptor potential cation channel subfamily M member 3, [Score=317, Expect=2e-88]; ENSG00000119121, TRPM6, transient receptor potential cation channel subfamily M member 6, [Score=316, Expect=4e-88]} {Mouse: ENSMUSG00000052387, Trpm3, transient receptor potential cation channel, subfamily M, member 3, [Score=319, Expect=4e-90]} {Dmel: FBgn0265194, Trpm, Transient receptor potential cation channel, subfamily M, [Score=309, Expect=7e-88]} {Celegans: WBGene00001796, gtl-2, Gon-Two Like (TRP subfamily), [Score=255, Expect=4e-69]} {Smed: dd_Smed_v6_9288_0_1, dd_Smed_v6_9288_0_1, [Score=418, Expect=3e-126]} {RNA1509_17593} {RNA1310_1651, RNA1509_17593} {RNA1509_17593, RNA815_2281} |
| 19. | MligTC455_11558 | 137 | 2.85 | Mlig455_058259 | Neo: - Age: logFC(26M/2M)=-0.792 |
1.838 | - | - | - | 0.953 | - | 0.885 | Mlig455_058259 {REF} {Length: 896} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=19.9]} {RNA1509_58923} {RNA1310_41706, RNA1509_58923} {RNA1509_58923, RNA815_20876} | |
| 20. | MligTC455_12277 | 22 | 0.46 | Mlig455_025521 | Neo: - Age: Down-Up-Down |
CASP3 | 1.838 | - | - | - | 0.888 | - | 0.950 | Mlig455_025521 {REF} {Length: 4174} {Pfam: Protein kinase domain [PF00069.27, score=194.8]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=181.9]; Caspase domain [PF00656.24, score=110.6]} {Human: ENSG00000164305, CASP3, caspase 3, [Score=135, Expect=8e-35]; ENSG00000138794, CASP6, caspase 6, [Score=129, Expect=2e-32]} {Mouse: ENSMUSG00000031628, Casp3, caspase 3, [Score=132, Expect=6e-34]; ENSMUSG00000028914, Casp9, caspase 9, [Score=129, Expect=4e-31]} {Dmel: FBgn0010501, Dcp-1, Death caspase-1, [Score=113, Expect=5e-27]} {Celegans: WBGene00000417, ced-3, Cell death protein 3 Cell death protein 3 subunit 1 Cell death protein 3 subunit 2, [Score=130, Expect=2e-33]} {Smed: dd_Smed_v6_10708_0_1, dd_Smed_v6_10708_0_1, [RH, Score=124, Expect=4e-30]} {RNA1509_16483} {RNA1310_10829} {RNA815_3681.1} |
| 21. | MligTC455_50362 | 295 | 6.16 | Mlig455_012011 | Neo: - Age: logFC(26M/2M)=1.080 Region-enriched R2: 3.396/0.00236 |
1.836 | - | - | - | 0.870 | - | 0.966 | Mlig455_012011 {REF} {Length: 947} {RNA1509_58656} {RNA1310_57201.1} {RNA815_30531.1} | |
| 22. | MligTC455_19249 | 90 | 1.86 | Mlig455_054092 | Neo: - Age: Down-Up-Up Region-enriched R2: 7.298/0.00139 |
1.832 | - | - | - | 0.964 | - | 0.868 | Mlig455_054092 {REF} {Length: 667} {TRANSSPLICED} {RNA1509_57448} {RNA1310_51394, RNA1509_57448} {RNA1509_57448, RNA815_26076} | |
| 23. | MligTC455_12545 | 37 | 0.76 | Mlig455_069121 | Neo: - Age: - |
1.829 | - | - | - | 0.861 | - | 0.968 | Mlig455_069121 {REF} {Length: 1966} {RNA1310_47776.1} {RNA815_35125} | |
| 24. | MligTC455_13902 | 400 | 8.32 | Mlig455_011022, Mlig455_011835, Mlig455_013117 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.562 Region-specific R2: 6.064 Region-enriched R2: 5.080/0.00072 |
1.828 | - | - | - | 0.952 | - | 0.876 | Mlig455_011022 {REF} {Length: 631} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_011835 {REF} {Length: 2387} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_013117 {REF} {Length: 1663} {NoTransDecoderORF} {RNA1310_40518} {RNA815_20411.2} |
|
| 25. | MligTC455_53480 | 31 | 0.64 | Mlig455_043390, Mlig455_043414, Mlig455_043557 | Neo: - Age: - |
WSCD2 | 1.825 | 0.854 | - | - | 0.971 | - | - | Mlig455_043390 {REF} {Length: 1215} {Pfam: WSC domain [PF01822.21, score=50.0]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=59.7, Expect=2e-10]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=59.7, Expect=2e-10]} {RNA1310_30552} {RNA815_18175} Mlig455_043414 {REF} {Length: 1144} {Pfam: WSC domain [PF01822.21, score=46.1]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=56.2, Expect=8e-09]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=57.4, Expect=3e-09]} {RNA1310_30552} {RNA815_18175} Mlig455_043557 {REF} {Length: 1209} {Pfam: WSC domain [PF01822.21, score=32.4]} {RNA1310_30552} {RNA815_18175} |
| 26. | MligTC455_40873 | 337 | 7.01 | Mlig455_035925 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.444 Region-enriched R2: 2.306/0.00166 |
INPP1 | 1.819 | - | - | - | 0.848 | - | 0.971 | Mlig455_035925 {REF} {Length: 4016} {Pfam: Inositol monophosphatase family [PF00459.27, score=103.7]} {Human: ENSG00000151689, INPP1, inositol polyphosphate-1-phosphatase, [RH, Score=256, Expect=1e-80]} {Mouse: ENSMUSG00000026102, Inpp1, inositol polyphosphate-1-phosphatase, [Score=288, Expect=1e-93]} {Dmel: FBgn0016672, Ipp, Inositol polyphosphate 1-phosphatase, [Score=241, Expect=1e-75]} {Celegans: WBGene00044063, bpnt-1, 3'(2'), 5'-BisPhosphate NucleoTidase 1 homolog, [Score=77.0, Expect=2e-15]} {Smed: dd_Smed_v6_9612_0_1, dd_Smed_v6_9612_0_1, [RH, Score=194, Expect=1e-57]} {RNA1509_32464} {RNA1310_21278.1} {RNA815_20760} |
| 27. | MligTC455_13376 | 101 | 2.1 | Mlig455_040613 | Neo: - Age: - Region-specific R2: 4.973 Region-enriched R2: 6.158/0.00016 |
1.818 | 0.861 | - | - | - | - | 0.957 | Mlig455_040613 {REF} {Length: 2807} {RNA1310_27894} {RNA815_60961} | |
| 28. | MligTC455_36950 | 42 | 0.88 | Mlig455_022867 | Neo: - Age: - |
KIAA1217 | 1.818 | - | - | - | 0.952 | - | 0.866 | Mlig455_022867 {REF} {Length: 3173} {Human: ENSG00000120549, KIAA1217, KIAA1217, [RH, Score=72.4, Expect=3e-12]} {Mouse: ENSMUSG00000036617, Etl4, enhancer trap locus 4, [RH, Score=65.9, Expect=2e-10]} {Dmel: FBgn0023531, CG32809, [Score=70.9, Expect=4e-12]} {Celegans: WBGene00022180, Y71H2AM.15, [RH, Score=62.0, Expect=1e-09]} {RNA1310_85458} {RNA815_59686} |
| 29. | MligTC455_12971 | 15 | 0.3 | Mlig455_023929 | Neo: - Age: - |
1.809 | 0.854 | - | - | 0.955 | - | - | Mlig455_023929 {REF} {Length: 305} {NoTransDecoderORF} | |
| 30. | MligTC455_39665 | 112 | 2.33 | Mlig455_023730 | Neo: - Age: - |
EPHA7 | 1.805 | - | - | - | 0.967 | - | 0.838 | Mlig455_023730 {REF} {Length: 3591} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=285.8]; Protein kinase domain [PF00069.27, score=130.1]; Ephrin receptor ligand binding domain [PF01404.21, score=107.2]; Fibronectin type III domain [PF00041.23, score=95.6]; Ephrin type-A receptor 2 transmembrane domain [PF14575.8, score=57.6]; SAM domain (Sterile alpha motif) [PF07647.19, score=55.1]; SAM domain (Sterile alpha motif) [PF00536.32, score=50.6]; Purple acid Phosphatase, N-terminal domain [PF16656.7, score=25.8]; ABC1 atypical kinase-like domain [PF03109.18, score=20.9]; Tyrosine-protein kinase ephrin type A/B receptor-like [PF07699.15, score=19.2]} {Human: ENSG00000135333, EPHA7, EPH receptor A7, [Score=658, Expect=0.0]; ENSG00000145242, EPHA5, EPH receptor A5, [Score=647, Expect=0.0]; ENSG00000116106, EPHA4, EPH receptor A4, [Score=646, Expect=0.0]} {Mouse: ENSMUSG00000028289, Epha7, Eph receptor A7, [Score=659, Expect=0.0]; ENSMUSG00000026235, Epha4, Eph receptor A4, [Score=651, Expect=0.0]; ENSMUSG00000029245, Epha5, Eph receptor A5, [Score=648, Expect=0.0]} {Dmel: FBgn0025936, Eph, Eph receptor tyrosine kinase, [Score=609, Expect=0.0]} {Celegans: WBGene00006868, vab-1, Ephrin receptor 1, [Score=458, Expect=2e-143]} {Smed: dd_Smed_v6_16928_0_1, dd_Smed_v6_16928_0_1, [Score=552, Expect=7e-180]} {RNA1509_24016} {RNA1310_2298.1} {RNA815_19987} |
| 31. | MligTC455_12183 | 53 | 1.11 | Mlig455_004166, Mlig455_004190 | Neo: - Age: - Region-enriched R2: 4.930/0.01881 |
1.798 | - | - | - | 0.977 | - | 0.821 | Mlig455_004166 {REF} {Length: 2818} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=57.4]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=29.1]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=55.5, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=8e-12]} {RNA1310_64973} {RNA815_58453} Mlig455_004190 {REF} {Length: 2742} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.7]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=28.6]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=56.2, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=1e-11]} {RNA1310_62602} {RNA815_58453} |
|
| 32. | MligTC455_21033 | 1129 | 23.52 | Mlig455_010672 | Neo: - Age: logFC(26M/2M)=0.356 Region-specific R2: 3.326 Region-enriched R2: 2.739/0.00000 Regeneration-downregulated R2: -1.967 Regeneration-depleted R2: -1.967 |
1.798 | - | - | - | 0.969 | - | 0.829 | Mlig455_010672 {REF} {Length: 829} {RNA1509_30331, RNA1509_45731} {RNA1310_60944, RNA1509_30331, RNA1509_45731} {RNA1509_30331, RNA1509_45731, RNA815_27381.1} | |
| 33. | MligTC455_50694 | 602 | 12.54 | Mlig455_058794, Mlig455_070066 | Neo: - Age: Down-Down-Up Region-specific R2: 5.478 Region-enriched R2: 3.805/0.01454 |
1.798 | - | - | - | 0.951 | - | 0.847 | Mlig455_058794 {REF} {Length: 776} {RNA1310_76208} {RNA815_49041} Mlig455_070066 {REF} {Length: 781} {RNA1310_76208} {RNA815_49041} |
|
| 34. | MligTC455_19716 | 35 | 0.73 | Mlig455_008148 | Neo: - Age: - |
NPY1R | 1.797 | - | - | - | 0.967 | - | 0.830 | Mlig455_008148 {REF} {Length: 3212} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=183.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=46.8]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=36.4]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [RH, Score=167, Expect=8e-47]} {Mouse: ENSMUSG00000031932, Gpr83, G protein-coupled receptor 83, [RH, Score=170, Expect=8e-48]; ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [RH, Score=167, Expect=7e-47]} {Dmel: FBgn0036934, sNPF-R, short neuropeptide F receptor, [RH, Score=256, Expect=1e-78]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [RH, Score=220, Expect=3e-67]} {Smed: dd_Smed_v6_10020_0_1, dd_Smed_v6_10020_0_1, [RH, Score=336, Expect=1e-112]} {RNA1310_21371} {RNA815_7986} |
| 35. | MligTC455_38284 | 12 | 0.25 | Mlig455_015813 | Neo: - Age: - |
1.788 | - | - | - | 0.959 | - | 0.829 | Mlig455_015813 {REF} {Length: 1163} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=61.6, Expect=2e-11]} {RNA1310_89599} {RNA815_16968} | |
| 36. | MligTC455_51313 | 10 | 0.21 | Mlig455_042838, Mlig455_045872 | Neo: - Age: - |
1.787 | - | - | - | 0.988 | - | 0.799 | Mlig455_042838 {REF} {Length: 1317} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=32.4]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=30.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=27.6]} {Smed: dd_Smed_v6_26560_0_2, dd_Smed_v6_26560_0_2, [Score=104, Expect=4e-25]} Mlig455_045872 {REF} {Length: 1317} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=32.4]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=30.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=27.6]} {Smed: dd_Smed_v6_26560_0_2, dd_Smed_v6_26560_0_2, [Score=104, Expect=4e-25]} |
|
| 37. | MligTC455_19552 | 288 | 6 | Mlig455_055936, Mlig455_068188 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.424 Region-specific R2: 6.302 Region-enriched R2: 4.919/0.00633 Regeneration-depleted R4: -5.607 |
1.781 | - | - | - | 0.957 | - | 0.824 | Mlig455_055936 {REF} {Length: 665} {RNA1310_71052} {RNA815_36745} Mlig455_068188 {REF} {Length: 714} {RNA1310_71052} {RNA815_36745} |
|
| 38. | MligTC455_19235 | 18 | 0.38 | Mlig455_013768 | Neo: - Age: - |
1.78 | - | - | - | 0.955 | - | 0.825 | Mlig455_013768 {REF} {Length: 2312} {Pfam: Glycine rich protein [PF12810.9, score=36.9]; PAN domain [PF00024.28, score=24.7]} {RNA1310_126710} {RNA815_35307} | |
| 39. | MligTC455_27881 | 54 | 1.12 | Mlig455_062466 | Neo: - |
1.777 | - | - | - | - | 0.982 | 0.795 | Mlig455_062466 {REF} {Length: 5589} {Pfam: Mab-21 protein [PF03281.16, score=30.3]} {RNA1509_26004} {RNA1310_3906.1} {RNA815_1664.1} | |
| 40. | MligTC455_38875 | 37 | 0.78 | Mlig455_029375, Mlig455_029415 | Neo: - Age: logFC(26M/2M)=-0.939 |
GRIK2 | 1.775 | - | - | - | 0.963 | - | 0.812 | Mlig455_029375 {REF} {Length: 3713} {Pfam: Ligand-gated ion channel [PF00060.28, score=88.9]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=58.3]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=34.5]; Receptor family ligand binding region [PF01094.30, score=20.4]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=136, Expect=2e-32]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=137, Expect=9e-33]} {Dmel: FBgn0038837, CG3822, [Score=150, Expect=4e-37]} {Celegans: WBGene00001613, glr-2, Glutamate receptor 2, [Score=126, Expect=1e-29]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=242, Expect=3e-72]} {RNA1310_67049} {RNA815_49856} Mlig455_029415 {REF} {Length: 2520} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=25.5]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=73.9, Expect=5e-14]} {RNA1310_74947} {RNA815_49856} |
| 41. | MligTC455_13846 | 32 | 0.67 | Mlig455_013761 | Neo: - Age: - |
CALM2 | 1.774 | - | - | - | 0.953 | - | 0.821 | Mlig455_013761 {REF} {Length: 941} {Pfam: EF hand [PF00036.34, score=94.2]; EF-hand domain [PF13405.8, score=86.1]; EF-hand domain pair [PF13499.8, score=83.6]; EF hand [PF13202.8, score=77.1]; EF-hand domain pair [PF13833.8, score=42.5]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=31.3]; EF-hand domain [PF14658.8, score=23.8]; Ca2+ insensitive EF hand [PF08726.12, score=21.5]; Caleosin related protein [PF05042.15, score=21.3]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=60.1, Expect=1e-11]; ENSG00000160014, CALM3, calmodulin 3, [Score=60.1, Expect=1e-11]; ENSG00000198668, CALM1, calmodulin 1, [Score=60.1, Expect=1e-11]; ENSG00000178363, CALML3, calmodulin like 3, [Score=59.3, Expect=2e-11]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=60.5, Expect=1e-11]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=60.1, Expect=8e-12]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=60.1, Expect=8e-12]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=59.7, Expect=1e-11]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=60.8, Expect=3e-12]} {Celegans: WBGene00019352, K03A1.4, [Score=70.9, Expect=8e-16]} {Smed: dd_Smed_v6_15455_0_1, dd_Smed_v6_15455_0_1, [RH, Score=97.4, Expect=1e-26]} {RNA1310_47452} {RNA815_31258} |
| 42. | MligTC455_17177 | 103 | 2.15 | Mlig455_048992, Mlig455_049009 | Neo: - Age: Down-Down-Up |
1.768 | - | - | - | 0.969 | - | 0.799 | Mlig455_048992 {REF} {Length: 1836} {RNA1509_44702} {RNA1310_14743, RNA1509_44702} {RNA1509_44702, RNA815_20669.1} Mlig455_049009 {REF} {Length: 1823} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} |
|
| 43. | MligTC455_34279 | 55 | 1.15 | Mlig455_056988 | Neo: - Age: - |
ZBTB16 | 1.765 | - | - | - | 0.955 | - | 0.810 | Mlig455_056988 {REF} {Length: 3794} {Pfam: C2H2-type zinc-finger domain [PF13909.8, score=57.5]; Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=23.3]} {Human: ENSG00000109906, ZBTB16, zinc finger and BTB domain containing 16, [Score=52.8, Expect=2e-06]; ENSG00000084093, REST, RE1 silencing transcription factor, [Score=52.0, Expect=5e-06]} {Mouse: ENSMUSG00000026135, Zfp142, zinc finger protein 142, [Score=62.4, Expect=3e-09]} {Dmel: FBgn0262160, CG9932, [RH, Score=66.6, Expect=9e-11]} {Celegans: WBGene00001824, hbl-1, Hunchback-like protein, [Score=50.4, Expect=6e-06]} {Smed: dd_Smed_v6_36433_0_1, dd_Smed_v6_36433_0_1, [Score=176, Expect=9e-48]} {RNA1509_19024} {RNA1310_45424} {RNA815_39699} |
| 44. | MligTC455_44966 | 574 | 11.95 | Mlig455_036578, Mlig455_057773 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.756 Region-specific R2: 7.016 Region-enriched R2: 7.690/0.00000 |
1.763 | - | - | - | 0.953 | - | 0.810 | Mlig455_036578 {REF} {Length: 1101} {RNA1509_34765} {RNA1310_57079} {RNA815_29388} Mlig455_057773 {REF} {Length: 629} {RNA1509_34765} {RNA1310_57079, RNA1509_34765} {RNA1509_34765, RNA815_29388} |
|
| 45. | MligTC455_14483 | 140 | 2.92 | Mlig455_028240 | Neo: - Age: - Region-enriched R2: 6.203/0.04837 |
1.762 | - | - | - | 0.962 | - | 0.800 | Mlig455_028240 {REF} {Length: 728} {RNA1310_111517} {RNA815_9716} | |
| 46. | MligTC455_17051 | 22 | 0.46 | Mlig455_042552 | Neo: - Age: - |
GRIA4 | 1.761 | - | - | - | 0.962 | - | 0.799 | Mlig455_042552 {REF} {Length: 3307} {Pfam: Ligand-gated ion channel [PF00060.28, score=83.3]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=45.2]; Receptor family ligand binding region [PF01094.30, score=25.8]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=19.8]} {Human: ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=139, Expect=2e-33]} {Mouse: ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=139, Expect=3e-33]} {Dmel: FBgn0038837, CG3822, [Score=142, Expect=2e-34]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=109, Expect=2e-24]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=246, Expect=7e-74]} {RNA1310_33224} {RNA815_17044} |
| 47. | MligTC455_33317 | 89 | 1.85 | Mlig455_027356 | Neo: - Age: logFC(26M/2M)=0.510 |
CASK | 1.76 | - | - | - | 0.803 | - | 0.957 | Mlig455_027356 {REF} {Length: 7545} {Pfam: PDZ domain [PF00595.26, score=49.9]; L27 domain [PF02828.18, score=40.8]} {Human: ENSG00000147044, CASK, calcium/calmodulin dependent serine protein kinase, [Score=208, Expect=3e-59]} {Mouse: ENSMUSG00000031012, Cask, calcium/calmodulin-dependent serine protein kinase (MAGUK family), [Score=207, Expect=9e-57]} {Dmel: FBgn0013759, CASK, [Score=193, Expect=7e-52]} {Celegans: WBGene00002991, lin-2, [Score=124, Expect=1e-29]} {Smed: dd_Smed_v6_7723_0_4, dd_Smed_v6_7723_0_4, [Score=217, Expect=1e-60]} {RNA1509_30764} {RNA1310_4720.1} {RNA815_18816} |
| 48. | MligTC455_34525 | 52 | 1.08 | Mlig455_021566 | Neo: - Age: Down-Up-Down |
GNAI1 | 1.76 | - | - | - | 0.962 | - | 0.798 | Mlig455_021566 {REF} {Length: 3532} {Pfam: G-protein alpha subunit [PF00503.22, score=404.9]; ADP-ribosylation factor family [PF00025.23, score=56.0]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=20.1]; Gtr1/RagA G protein conserved region [PF04670.14, score=19.4]} {Human: ENSG00000127955, GNAI1, G protein subunit alpha i1, [Score=486, Expect=2e-171]; ENSG00000114353, GNAI2, G protein subunit alpha i2, [Score=481, Expect=3e-169]; ENSG00000065135, GNAI3, G protein subunit alpha i3, [Score=474, Expect=1e-166]} {Mouse: ENSMUSG00000057614, Gnai1, guanine nucleotide binding protein (G protein), alpha inhibiting 1, [Score=486, Expect=2e-171]; ENSMUSG00000032562, Gnai2, guanine nucleotide binding protein (G protein), alpha inhibiting 2, [Score=475, Expect=5e-167]; ENSMUSG00000000001, Gnai3, guanine nucleotide binding protein (G protein), alpha inhibiting 3, [Score=474, Expect=1e-166]} {Dmel: FBgn0001104, Galphai, G protein alpha i subunit, [Score=468, Expect=2e-164]} {Celegans: WBGene00001648, goa-1, Guanine nucleotide-binding protein G(o) subunit alpha, [Score=446, Expect=5e-156]} {Smed: dd_Smed_v6_12112_0_1, dd_Smed_v6_12112_0_1, [RH, Score=598, Expect=0.0]} {RNA1509_45426} {RNA1310_26920, RNA1509_45426} {RNA1509_45426, RNA815_11718} |
| 49. | MligTC455_11701 | 54 | 1.12 | Mlig455_042837, Mlig455_045855, Mlig455_045871 | Neo: - Age: - |
1.758 | - | - | - | 0.959 | - | 0.799 | Mlig455_042837 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} Mlig455_045855 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} Mlig455_045871 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} |
|
| 50. | MligTC455_38949 | 105 | 2.19 | Mlig455_065209 | Neo: - Age: - Region-specific R2: 7.633 Region-enriched R2: 10.088/0.00000 |
1.758 | - | - | - | 0.959 | - | 0.799 | Mlig455_065209 {REF} {Length: 591} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=23.2]} {RNA1509_44618} {RNA1310_63839, RNA1509_44618} {RNA1509_44618, RNA815_35329} | |
| 51. | MligTC455_18834 | 33 | 0.68 | Mlig455_000603 | Neo: - Age: - |
1.756 | - | - | - | 0.957 | - | 0.799 | Mlig455_000603 {REF} {Length: 1888} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.2]} {RNA1310_27913} {RNA815_25050} | |
| 52. | MligTC455_52629 | 472 | 9.83 | Mlig455_059435 | Neo: - Age: Down-Up-Up Region-specific R2: 6.775 Region-enriched R2: 6.727/0.00002 |
1.755 | - | - | - | 0.956 | - | 0.799 | Mlig455_059435 {REF} {Length: 726} {RNA1509_48505} {RNA1310_62885} {RNA815_39881} | |
| 53. | MligTC455_18945 | 41 | 0.86 | Mlig455_031602 | Neo: - Age: - |
1.754 | - | - | - | 0.955 | - | 0.799 | Mlig455_031602 {REF} {Length: 914} {RNA1310_75361} {RNA815_24378} | |
| 54. | MligTC455_43714 | 152 | 3.18 | Mlig455_000684, Mlig455_000736 | Neo: - Age: - |
1.754 | - | - | - | 0.955 | - | 0.799 | Mlig455_000684 {REF} {Length: 796} {Pfam: WSC domain [PF01822.21, score=42.8]} {RNA1310_46313} {RNA815_23250} Mlig455_000736 {REF} {Length: 797} {Pfam: WSC domain [PF01822.21, score=42.8]} {RNA1310_46313} {RNA815_23250} |
|
| 55. | MligTC455_47675 | 2101 | 43.77 | Mlig455_061675, Mlig455_063136 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.812 Region-specific R2: 4.381 Region-enriched R2: 4.099/0.00000 |
CLEC18C | 1.754 | - | - | - | 0.952 | - | 0.802 | Mlig455_061675 {REF} {Length: 2392} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=60.3]} {Human: ENSG00000157335, CLEC18C, C-type lectin domain family 18 member C, [RH, Score=75.5, Expect=1e-13]; ENSG00000140839, CLEC18B, C-type lectin domain family 18 member B, [RH, Score=75.1, Expect=1e-13]} {Mouse: ENSMUSG00000020213, Glipr1l1, GLI pathogenesis-related 1 like 1, [Score=77.8, Expect=1e-15]; ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=75.9, Expect=7e-15]} {Celegans: WBGene00003055, lon-1, LONg, [Score=62.8, Expect=2e-10]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [Score=134, Expect=5e-33]} {RNA1509_48080} {RNA1310_16102.1} {RNA815_9265} Mlig455_063136 {REF} {Length: 2649} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=60.7]} {Human: ENSG00000157335, CLEC18C, C-type lectin domain family 18 member C, [RH, Score=77.8, Expect=1e-14]; ENSG00000140839, CLEC18B, C-type lectin domain family 18 member B, [RH, Score=77.4, Expect=1e-14]; ENSG00000157322, CLEC18A, C-type lectin domain family 18 member A, [RH, Score=77.0, Expect=2e-14]} {Mouse: ENSMUSG00000020213, Glipr1l1, GLI pathogenesis-related 1 like 1, [Score=78.2, Expect=5e-16]; ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=76.3, Expect=3e-14]} {Celegans: WBGene00003055, lon-1, LONg, [Score=63.5, Expect=6e-11]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=136, Expect=3e-34]} {RNA1509_48080} {RNA1310_16102.1} {RNA815_9265} |
| 56. | MligTC455_49334 | 86 | 1.78 | Mlig455_037751 | Neo: - Age: - |
1.754 | - | - | - | 0.955 | - | 0.799 | Mlig455_037751 {REF} {Length: 708} {RNA1509_25826} {RNA1310_47741} {RNA815_23874} | |
| 57. | MligTC455_43715 | 48 | 0.99 | Mlig455_034191 | Neo: - Age: Down-Up-Down Region-enriched R2: 7.969/0.00817 |
1.752 | - | - | - | 0.953 | - | 0.799 | Mlig455_034191 {REF} {Length: 895} {Pfam: WSC domain [PF01822.21, score=39.9]; PAN domain [PF14295.8, score=21.0]; PAN domain [PF00024.28, score=19.9]} {RNA1310_46313} {RNA815_23250} | |
| 58. | MligTC455_17363 | 62 | 1.28 | Mlig455_003936 | Neo: - Age: - |
1.751 | - | - | - | 0.952 | - | 0.799 | Mlig455_003936 {REF} {Length: 1252} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=45.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=26.4]} {RNA1310_47889} {RNA815_24646} | |
| 59. | MligTC455_17578 | 447 | 9.32 | Mlig455_010738 | Neo: - Age: Down-Up-Up Region-specific R2: 8.320 Region-enriched R2: 9.793/0.00000 |
1.746 | - | - | - | 0.960 | - | 0.786 | Mlig455_010738 {REF} {Length: 642} {RNA1509_48297, RNA1509_55742} {RNA1310_84623, RNA1509_48297, RNA1509_55742} {RNA1509_48297, RNA1509_55742, RNA815_45356} | |
| 60. | MligTC455_49919 | 745 | 15.52 | Mlig455_017182, Mlig455_048150 | Neo: - Age: - Region-specific R2: 7.180 Region-enriched R2: 7.978/0.00000 Regeneration-downregulated R2: -4.649 Regeneration-depleted R2: -4.649 |
1.745 | - | - | - | 0.950 | - | 0.795 | Mlig455_017182 {REF} {Length: 576} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1310_60849, RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1509_35830, RNA1509_49816, RNA1509_53987, RNA815_31347} Mlig455_048150 {REF} {Length: 574} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830} {RNA1310_60849} {RNA815_31347} |
|
| 61. | MligTC455_51334 | 326 | 6.78 | Mlig455_011442, Mlig455_061180 | Neo: - |
1.743 | - | - | - | 0.950 | - | 0.793 | Mlig455_011442 {REF} {Length: 742} {RNA1310_57576.1} {RNA815_29867} Mlig455_061180 {REF} {Length: 769} {RNA1310_57576.1} {RNA815_29867} |
|
| 62. | MligTC455_42520 | 221 | 4.6 | Mlig455_051277 | Neo: - Age: Down-Up-Up Region-specific R2: 7.331 Region-enriched R2: 7.171/0.00000 Regeneration-downregulated R2: -3.384 Regeneration-depleted R2: -3.384 |
1.74 | - | - | - | 0.953 | - | 0.787 | Mlig455_051277 {REF} {Length: 969} {RNA1310_42329} {RNA815_20649} | |
| 63. | MligTC455_06458 | 109 | 2.27 | Mlig455_058915 | Neo: - Age: - |
TMEM184B | 1.737 | - | - | - | 0.781 | - | 0.956 | Mlig455_058915 {REF} {Length: 2946} {Pfam: Organic solute transporter Ostalpha [PF03619.18, score=289.5]} {Human: ENSG00000198792, TMEM184B, transmembrane protein 184B, [RH, Score=437, Expect=5e-152]} {Mouse: ENSMUSG00000009035, Tmem184b, transmembrane protein 184b, [RH, Score=432, Expect=5e-150]} {Dmel: FBgn0035236, CG12004, [RH, Score=446, Expect=2e-154]} {Celegans: WBGene00009574, F40E10.6, [RH, Score=473, Expect=2e-166]} {Smed: dd_Smed_v6_3881_1_1, dd_Smed_v6_3881_1_1, [RH, Score=461, Expect=2e-162]} {RNA1310_13503.1} {RNA815_394.1} |
| 64. | MligTC455_18748 | 104 | 2.17 | Mlig455_024985, Mlig455_024999 | Neo: - Age: - Region-enriched R2: 6.002/0.00016 |
GRIK4 | 1.736 | - | - | - | 0.959 | - | 0.777 | Mlig455_024985 {REF} {Length: 1514} {Pfam: Ligand-gated ion channel [PF00060.28, score=76.7]; Receptor family ligand binding region [PF01094.30, score=31.5]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=20.6]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=122, Expect=1e-27]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=124, Expect=1e-28]} {Dmel: FBgn0038837, CG3822, [Score=120, Expect=1e-27]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=99.0, Expect=5e-21]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=196, Expect=2e-55]} {RNA1509_35538} {RNA1310_47299} {RNA815_38321} Mlig455_024999 {REF} {Length: 3567} {Pfam: Ligand-gated ion channel [PF00060.28, score=76.7]; Receptor family ligand binding region [PF01094.30, score=31.5]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=20.6]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=122, Expect=1e-27]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=124, Expect=1e-28]} {Dmel: FBgn0038837, CG3822, [Score=120, Expect=1e-27]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=99.0, Expect=5e-21]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=196, Expect=2e-55]} {RNA1509_35538} {RNA1310_7578, RNA1509_35538} {RNA1509_35538, RNA815_4987} |
| 65. | MligTC455_12438 | 17 | 0.35 | Mlig455_009594 | Neo: - Age: - |
1.735 | - | - | - | 0.959 | - | 0.776 | Mlig455_009594 {REF} {Length: 2044} {RNA1310_39190} {RNA815_29274} | |
| 66. | MligTC455_46451 | 229 | 4.76 | Mlig455_017183 | Neo: - Age: Down-Up-Down Region-specific R2: 5.510 Region-enriched R2: 5.394/0.00018 Regeneration-downregulated R2: -2.986 Regeneration-depleted R2: -2.986 |
1.733 | - | - | - | 0.951 | - | 0.782 | Mlig455_017183 {REF} {Length: 657} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.6]} {RNA1310_62963} {RNA815_31352} | |
| 67. | MligTC455_26322 | 65 | 1.35 | Mlig455_042546 | Neo: - Age: - |
GRID2 | 1.732 | - | - | - | 0.962 | - | 0.770 | Mlig455_042546 {REF} {Length: 3217} {Pfam: Ligand-gated ion channel [PF00060.28, score=79.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=49.4]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=35.5]; Receptor family ligand binding region [PF01094.30, score=33.7]} {Human: ENSG00000152208, GRID2, glutamate ionotropic receptor delta type subunit 2, [Score=127, Expect=3e-29]} {Mouse: ENSMUSG00000071424, Grid2, glutamate receptor, ionotropic, delta 2, [Score=129, Expect=5e-30]} {Dmel: FBgn0039916, Ekar, Eye-enriched kainate receptor, [Score=133, Expect=1e-31]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=105, Expect=6e-23]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=238, Expect=8e-71]} {RNA1310_27694} {RNA815_34664} |
| 68. | MligTC455_40625 | 16 | 0.34 | Mlig455_050210 | Neo: - Age: - |
CD209 | 1.732 | - | - | - | 0.959 | - | 0.773 | Mlig455_050210 {REF} {Length: 1597} {Pfam: Lectin C-type domain [PF00059.23, score=26.2]} {Human: ENSG00000090659, CD209, CD209 molecule, [Score=48.1, Expect=7e-06]} {Mouse: ENSMUSG00000079168, Cd209g, CD209g antigen, [Score=45.8, Expect=1e-05]} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=60.1, Expect=8e-11]} {RNA1509_35402} {RNA1310_58025} {RNA815_61888} |
| 69. | MligTC455_17178 | 54 | 1.12 | Mlig455_067758 | Neo: - Age: - Region-enriched R2: 7.471/0.00007 |
1.731 | - | - | - | 0.955 | - | 0.776 | Mlig455_067758 {REF} {Length: 2301} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} | |
| 70. | MligTC455_17895 | 389 | 8.1 | Mlig455_060774 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.268 Region-specific R2: 7.424 Region-enriched R2: 6.488/0.00062 Regeneration-downregulated R2: -4.133 Regeneration-depleted R2: -4.133 |
1.727 | - | - | - | 0.962 | - | 0.765 | Mlig455_060774 {REF} {Length: 1670} {RNA1509_34403} {RNA1310_35901, RNA1509_34403} {RNA1509_34403, RNA815_35590} | |
| 71. | MligTC455_10899 | 46 | 0.95 | Mlig455_013784, Mlig455_013915 | Neo: - Age: - |
1.725 | - | - | - | 0.969 | - | 0.756 | Mlig455_013784 {REF} {Length: 1362} {Pfam: Glycine rich protein [PF12810.9, score=20.8]} {RNA1509_28715} {RNA1310_91773} {RNA815_35307} Mlig455_013915 {REF} {Length: 1516} {Pfam: Glycine rich protein [PF12810.9, score=20.3]} {RNA1509_28715} {RNA1310_91773} {RNA815_35307} |
|
| 72. | MligTC455_46452 | 134 | 2.79 | Mlig455_048151 | Neo: - Age: - Region-specific R2: 6.389 Region-enriched R2: 7.075/0.00014 Regeneration-downregulated R2: -3.162 Regeneration-depleted R2: -3.162 |
1.721 | - | - | - | 0.957 | - | 0.764 | Mlig455_048151 {REF} {Length: 618} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=25.7]} {RNA1310_62963} {RNA815_31352} | |
| 73. | MligTC455_53339 | 361 | 7.52 | Mlig455_044792, Mlig455_044816, Mlig455_055565 | Neo: - Age: - Region-enriched R2: 2.402/0.04439 |
DMBT1 | 1.719 | - | - | - | 0.763 | - | 0.956 | Mlig455_044792 {REF} {Length: 2555} {Pfam: Zona pellucida-like domain [PF00100.25, score=90.4]; Scavenger receptor cysteine-rich domain [PF00530.20, score=77.7]} {Human: ENSG00000187908, DMBT1, deleted in malignant brain tumors 1, [Score=67.0, Expect=8e-11]} {Mouse: ENSMUSG00000008845, Cd163, CD163 antigen, [Score=58.2, Expect=3e-08]} {Smed: dd_Smed_v6_8185_0_1, dd_Smed_v6_8185_0_1, [Score=73.9, Expect=9e-14]} {RNA1509_36885} {RNA1310_10008} {RNA815_6134} Mlig455_044816 {REF} {Length: 2732} {Pfam: Zona pellucida-like domain [PF00100.25, score=89.0]; Scavenger receptor cysteine-rich domain [PF00530.20, score=78.1]} {Human: ENSG00000187908, DMBT1, deleted in malignant brain tumors 1, [Score=67.0, Expect=9e-11]} {Mouse: ENSMUSG00000008845, Cd163, CD163 antigen, [Score=56.6, Expect=8e-08]} {Smed: dd_Smed_v6_8185_0_1, dd_Smed_v6_8185_0_1, [Score=73.6, Expect=1e-13]} {RNA1509_36885} {RNA1310_10008, RNA1509_36885} {RNA1509_36885, RNA815_6134} Mlig455_055565 {REF} {Length: 2284} {Pfam: Scavenger receptor cysteine-rich domain [PF00530.20, score=79.3]; Zona pellucida-like domain [PF00100.25, score=35.8]} {Human: ENSG00000187908, DMBT1, deleted in malignant brain tumors 1, [Score=65.5, Expect=1e-10]} {Mouse: ENSMUSG00000008845, Cd163, CD163 antigen, [Score=56.6, Expect=4e-08]} {Smed: dd_Smed_v6_8185_0_1, dd_Smed_v6_8185_0_1, [Score=55.1, Expect=4e-08]} {RNA1509_36885} {RNA1310_10008} {RNA815_6134} |
| 74. | MligTC455_43838 | 100 | 2.08 | Mlig455_027740 | Neo: - Age: - |
SYT9 | 1.718 | - | - | - | 0.951 | - | 0.767 | Mlig455_027740 {REF} {Length: 2584} {Pfam: C2 domain [PF00168.32, score=117.5]} {Human: ENSG00000170743, SYT9, synaptotagmin 9, [Score=194, Expect=3e-56]} {Mouse: ENSMUSG00000062542, Syt9, synaptotagmin IX, [Score=194, Expect=4e-56]} {Dmel: FBgn0261090, Sytbeta, Synaptotagmin beta, [RH, Score=188, Expect=2e-53]} {Celegans: WBGene00004923, snt-3, SyNapTotagmin, [Score=152, Expect=1e-42]} {Smed: dd_Smed_v6_19328_0_1, dd_Smed_v6_19328_0_1, [RH, Score=164, Expect=1e-45]} {RNA1509_57021} {RNA1310_11363} {RNA815_14366} |
| 75. | MligTC455_25112 | 611 | 12.74 | Mlig455_020700 | Neo: - Age: Down-Down-Up Region-enriched R7: 1.981/0.01296 |
1.716 | - | - | - | 0.962 | - | 0.754 | Mlig455_020700 {REF} {Length: 831} {Celegans: WBGene00003748, nlp-10, Neuropeptide-Like Protein, [Score=46.6, Expect=8e-07]} {RNA1509_27832, RNA1509_36958} {RNA1310_50245, RNA1509_27832, RNA1509_36958} {RNA1509_27832, RNA1509_36958, RNA815_48543} | |
| 76. | MligTC455_10932 | 11 | 0.23 | Mlig455_022307, Mlig455_069887 | Neo: - Age: Down-Up-Up |
WSCD2 | 1.713 | 0.758 | - | - | 0.955 | - | - | Mlig455_022307 {REF} {Length: 844} {Pfam: WSC domain [PF01822.21, score=54.9]; PAN domain [PF00024.28, score=22.0]; MANEC domain [PF07502.16, score=19.4]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=59.7, Expect=6e-10]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=58.9, Expect=8e-10]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=58.5, Expect=8e-10]} {RNA1509_46267} {RNA1310_51656} {RNA815_29077.2} Mlig455_069887 {REF} {Length: 1280} {Pfam: WSC domain [PF01822.21, score=50.5]} {RNA1509_53783} {RNA1310_29335.2} {RNA815_9084.1} |
| 77. | MligTC455_42391 | 1050 | 21.88 | Mlig455_010516, Mlig455_061820, Mlig455_061856, Mlig455_061864 | Neo: - Age: Down-Up-Up |
1.699 | - | - | - | 0.960 | - | 0.739 | Mlig455_010516 {REF} {Length: 729} {RNA1509_38791} {RNA1310_69853, RNA1509_38791} {RNA1509_38791, RNA815_39199} Mlig455_061820 {REF} {Length: 705} {RNA1509_38791} {RNA1310_69853} {RNA815_39199} Mlig455_061856 {REF} {Length: 708} {RNA1509_38791} {RNA1310_69853} {RNA815_39199} Mlig455_061864 {REF} {Length: 1146} {RNA1509_38791} {RNA1310_69853} {RNA815_39199} |
|
| 78. | MligTC455_43137 | 118 | 2.46 | Mlig455_043159 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.878 Region-enriched R2: 5.988/0.00166 |
1.699 | 0.740 | - | - | 0.959 | - | - | Mlig455_043159 {REF} {Length: 1651} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=25.7]} {RNA1509_48871} {RNA1310_23692, RNA1509_48871} {RNA1509_48871, RNA815_11317} | |
| 79. | MligTC455_53839 | 106 | 2.21 | Mlig455_008195, Mlig455_069578 | Neo: - Age: - |
1.693 | 0.725 | - | - | 0.968 | - | - | Mlig455_008195 {REF} {Length: 2376} {Smed: dd_Smed_v6_4245_0_1, dd_Smed_v6_4245_0_1, [Score=54.7, Expect=8e-08]} {RNA1310_37888} {RNA815_29107} Mlig455_069578 {REF} {Length: 2376} {Smed: dd_Smed_v6_4245_0_1, dd_Smed_v6_4245_0_1, [Score=54.7, Expect=8e-08]} {RNA1310_37888} {RNA815_29107} |
|
| 80. | MligTC455_40405 | 83 | 1.72 | Mlig455_015672 | Neo: - Age: - Region-enriched R2: 4.956/0.00100 |
CHRNA9 | 1.692 | - | - | - | 0.959 | - | 0.733 | Mlig455_015672 {REF} {Length: 3935} {TRANSSPLICED} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=152.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.8]} {Human: ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=204, Expect=4e-59]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=202, Expect=2e-58]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=201, Expect=5e-58]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=200, Expect=2e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=199, Expect=5e-57]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=199, Expect=5e-57]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=199, Expect=1e-56]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=197, Expect=3e-55]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=196, Expect=1e-55]; ENSG00000117971, CHRNB4, cholinergic receptor nicotinic beta 4 subunit, [Score=194, Expect=5e-55]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=209, Expect=8e-61]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=205, Expect=4e-59]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=201, Expect=3e-58]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=201, Expect=4e-58]} {Celegans: WBGene00000050, acr-11, AcetylCholine Receptor, [Score=191, Expect=8e-55]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [RH, Score=446, Expect=1e-151]} {RNA1509_18288} {RNA1310_3728} {RNA815_3826.1} |
| 81. | MligTC455_21681 | 27 | 0.56 | Mlig455_004824, Mlig455_004903 | Neo: - Age: - |
1.691 | - | - | - | 0.968 | - | 0.723 | Mlig455_004824 {REF} {Length: 1006} {Pfam: Lectin C-type domain [PF00059.23, score=26.8]} {Mouse: ENSMUSG00000065987, Cd209b, CD209b antigen, [Score=50.1, Expect=7e-07]; ENSMUSG00000079168, Cd209g, CD209g antigen, [Score=48.1, Expect=2e-06]} {Smed: dd_Smed_v6_85740_0_1, dd_Smed_v6_85740_0_1, [Score=52.0, Expect=1e-08]} {RNA1310_61965} {RNA815_21285} Mlig455_004903 {REF} {Length: 1008} {Pfam: Lectin C-type domain [PF00059.23, score=26.8]} {Mouse: ENSMUSG00000065987, Cd209b, CD209b antigen, [Score=50.1, Expect=7e-07]; ENSMUSG00000079168, Cd209g, CD209g antigen, [Score=48.1, Expect=2e-06]} {Smed: dd_Smed_v6_85740_0_1, dd_Smed_v6_85740_0_1, [Score=52.0, Expect=1e-08]} {RNA1310_61965} {RNA815_21285} |
|
| 82. | MligTC455_16606 | 108 | 2.26 | Mlig455_034973, Mlig455_053711, Mlig455_060000 | Neo: - Age: - Region-enriched R2: 5.697/0.00617 |
GLRA2 | 1.689 | - | - | - | 0.961 | - | 0.728 | Mlig455_034973 {REF} {Length: 1000} {RNA1310_100434} Mlig455_053711 {REF} {Length: 2327} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=52.0]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=60.8, Expect=3e-09]; ENSG00000109738, GLRB, glycine receptor beta, [Score=60.1, Expect=5e-09]} {Mouse: ENSMUSG00000023267, Gabrr2, gamma-aminobutyric acid (GABA) C receptor, subunit rho 2, [Score=61.6, Expect=1e-09]; ENSMUSG00000028020, Glrb, glycine receptor, beta subunit, [Score=61.2, Expect=2e-09]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=60.5, Expect=2e-09]} {Dmel: FBgn0010240, Lcch3, Ligand-gated chloride channel homolog 3, [Score=58.9, Expect=6e-09]} {Celegans: WBGene00001587, ggr-2, GABA/Glycine Receptor family (See gbr), [Score=60.8, Expect=1e-09]} {RNA1310_56609} {RNA815_37711} Mlig455_060000 {REF} {Length: 2781} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=52.0]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=62.0, Expect=1e-09]; ENSG00000109738, GLRB, glycine receptor beta, [Score=60.1, Expect=5e-09]} {Mouse: ENSMUSG00000023267, Gabrr2, gamma-aminobutyric acid (GABA) C receptor, subunit rho 2, [Score=62.0, Expect=7e-10]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=62.0, Expect=7e-10]; ENSMUSG00000028020, Glrb, glycine receptor, beta subunit, [Score=61.2, Expect=2e-09]} {Dmel: FBgn0010240, Lcch3, Ligand-gated chloride channel homolog 3, [Score=58.9, Expect=5e-09]} {Celegans: WBGene00001587, ggr-2, GABA/Glycine Receptor family (See gbr), [Score=60.8, Expect=1e-09]} {RNA1509_50322} {RNA1310_56609} {RNA815_37711} |
| 83. | MligTC455_18333 | 273 | 5.7 | Mlig455_010935 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.059/0.00307 |
1.689 | - | - | - | 0.951 | - | 0.738 | Mlig455_010935 {REF} {Length: 510} {RNA1310_33328.2} {RNA815_15093.1} | |
| 84. | MligTC455_25113 | 762 | 15.87 | Mlig455_020768 | Neo: - Age: Down-Up-Down Region-enriched R7: 2.653/0.00004 |
1.688 | - | - | - | 0.953 | - | 0.735 | Mlig455_020768 {REF} {Length: 810} {Celegans: WBGene00003748, nlp-10, Neuropeptide-Like Protein, [Score=46.2, Expect=1e-06]} {RNA1509_36958} {RNA1310_50245} {RNA815_48543} | |
| 85. | MligTC455_19583 | 95 | 1.97 | Mlig455_010583, Mlig455_010602 | Neo: - Age: - Region-enriched R2: 6.442/0.00383 |
1.687 | - | - | - | 0.974 | - | 0.713 | Mlig455_010583 {REF} {Length: 2325} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=173.5]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [Score=320, Expect=4e-101]} {RNA1310_36131} {RNA815_32135} Mlig455_010602 {REF} {Length: 2432} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=182.9]} {Smed: dd_Smed_v6_15099_0_1, dd_Smed_v6_15099_0_1, [RH, Score=346, Expect=2e-110]} {RNA1310_36131} {RNA815_32135} |
|
| 86. | MligTC455_12847 | 25 | 0.51 | Mlig455_049599 | Neo: - Age: - |
1.684 | - | - | - | 0.984 | - | 0.700 | Mlig455_049599 {REF} {Length: 1963} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=67.4]; Olfactory receptor [PF13853.8, score=24.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=22.0]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.1]} {Dmel: FBgn0053696, CNMaR, CNMamide Receptor, [RH, Score=91.7, Expect=1e-19]} {Smed: dd_Smed_v6_35525_0_1, dd_Smed_v6_35525_0_1, [Score=144, Expect=1e-38]} {RNA1310_85894} {RNA815_45174} | |
| 87. | MligTC455_26519 | 183 | 3.82 | Mlig455_030983, Mlig455_069440 | Neo: - Age: - |
1.682 | - | - | - | 0.959 | - | 0.723 | Mlig455_030983 {REF} {Length: 688} {RNA1509_12904} {RNA1310_62229} {RNA815_56172} Mlig455_069440 {REF} {Length: 1096} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=54.9]} {RNA1509_35362} {RNA1310_21423.2} {RNA815_13686} |
|
| 88. | MligTC455_31345 | 102 | 2.12 | Mlig455_004435, Mlig455_004447 | Neo: - Age: - |
RTL1 | 1.677 | - | - | - | 0.969 | - | 0.708 | Mlig455_004435 {REF} {Length: 551} {RNA1310_70973} {RNA815_36768} Mlig455_004447 {REF} {Length: 2743} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=93.3]; Integrase zinc binding domain [PF17921.3, score=77.6]; RNase H-like domain found in reverse transcriptase [PF17919.3, score=45.9]} {Human: ENSG00000254656, RTL1, retrotransposon Gag like 1, [Score=75.9, Expect=2e-13]} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=255, Expect=1e-71]} {RNA1509_33330} {RNA1310_5975.2} {RNA815_11487} |
| 89. | MligTC455_52788 | 41 | 0.86 | Mlig455_016296 | Neo: - Age: - |
FCN1 | 1.674 | - | - | - | 0.715 | - | 0.959 | Mlig455_016296 {REF} {Length: 1559} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=167.4]} {Human: ENSG00000085265, FCN1, ficolin 1, [Score=141, Expect=2e-39]; ENSG00000160339, FCN2, ficolin 2, [Score=139, Expect=3e-39]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=134, Expect=2e-35]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [RH, Score=135, Expect=4e-37]} {Dmel: FBgn0003326, sca, scabrous, [RH, Score=128, Expect=4e-33]} {Celegans: WBGene00020516, T15B7.1, [Score=59.3, Expect=6e-10]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=110, Expect=4e-27]} {RNA1310_57278} {RNA815_33549} |
| 90. | MligTC455_18650 | 60 | 1.26 | Mlig455_061093 | Neo: - Age: - |
TNNT2 | 1.66 | 0.709 | - | - | 0.951 | - | - | Mlig455_061093 {REF} {Length: 1966} {Pfam: Troponin [PF00992.22, score=40.7]} {Human: ENSG00000118194, TNNT2, troponin T2, cardiac type, [RH, Score=60.5, Expect=1e-09]; ENSG00000130595, TNNT3, troponin T3, fast skeletal type, [RH, Score=60.1, Expect=8e-10]} {Mouse: ENSMUSG00000026414, Tnnt2, troponin T2, cardiac, [RH, Score=63.2, Expect=8e-11]; ENSMUSG00000061723, Tnnt3, troponin T3, skeletal, fast, [RH, Score=60.1, Expect=7e-10]} {Dmel: FBgn0004169, up, upheld, [Score=117, Expect=1e-29]} {Celegans: WBGene00006587, tnt-2, TropoNin T, [RH, Score=94.7, Expect=2e-21]} {Smed: dd_Smed_v6_375_0_1, dd_Smed_v6_375_0_1, [RH, Score=258, Expect=4e-84]} {RNA1509_55821} {RNA1310_24395} {RNA815_14986} |
| 91. | MligTC455_18168 | 39 | 0.81 | Mlig455_062580 | Neo: - Age: logFC(26M/2M)=-0.368 Regeneration-upregulated BL: 7.138 Regeneration-enriched BL: 7.138 |
CCDC157 | 1.658 | - | - | - | - | 0.952 | 0.706 | Mlig455_062580 {REF} {Length: 3389} {TRANSSPLICED} {Human: ENSG00000187860, CCDC157, coiled-coil domain containing 157, [RH, Score=185, Expect=1e-48]} {Mouse: ENSMUSG00000051427, Ccdc157, coiled-coil domain containing 157, [RH, Score=191, Expect=6e-51]} {Smed: dd_Smed_v6_10757_0_1, dd_Smed_v6_10757_0_1, [RH, Score=226, Expect=3e-63]} {RNA1509_20327} {RNA1310_8258, RNA1509_20327} {RNA1509_20327, RNA815_4255} |
| 92. | MligTC455_19298 | 52 | 1.08 | Mlig455_007404 | Neo: - Age: - |
IRX4 | 0.995 | - | - | - | - | - | 0.995 | Mlig455_007404 {REF} {Length: 1775} {Pfam: Homeobox KN domain [PF05920.13, score=53.9]; Homeodomain [PF00046.31, score=30.1]} {Human: ENSG00000113430, IRX4, iroquois homeobox 4, [RH, Score=149, Expect=2e-39]; ENSG00000159387, IRX6, iroquois homeobox 6, [RH, Score=147, Expect=6e-39]} {Mouse: ENSMUSG00000021604, Irx4, Iroquois homeobox 4, [RH, Score=150, Expect=5e-40]; ENSMUSG00000031738, Irx6, Iroquois homeobox 6, [RH, Score=145, Expect=1e-38]} {Dmel: FBgn0015919, caup, caupolican, [RH, Score=153, Expect=3e-40]} {Celegans: WBGene00007984, irx-1, Putative iroquois-class homeodomain protein irx-1, [RH, Score=124, Expect=1e-31]} {Smed: dd_Smed_v6_17352_0_1, dd_Smed_v6_17352_0_1, [RH, Score=159, Expect=3e-44]} {RNA1310_58105} {RNA815_61910} |
| 93. | MligTC455_41048 | 764 | 15.92 | Mlig455_045087 | Neo: - Age: logFC(26M/2M)=-0.302 |
TBX2 | 0.989 | - | - | - | - | 0.989 | - | Mlig455_045087 {REF} {Length: 2264} {Pfam: T-box [PF00907.24, score=261.7]} {Human: ENSG00000121068, TBX2, T-box 2, [Score=321, Expect=3e-101]; ENSG00000135111, TBX3, T-box 3, [Score=317, Expect=3e-99]} {Mouse: ENSMUSG00000018604, Tbx3, T-box 3, [Score=325, Expect=7e-103]; ENSMUSG00000000093, Tbx2, T-box 2, [Score=320, Expect=6e-101]} {Dmel: FBgn0000179, bi, bifid, [Score=320, Expect=8e-99]} {Celegans: WBGene00006543, tbx-2, T-box protein 2, [Score=288, Expect=2e-92]} {Smed: dd_Smed_v6_11693_0_1, dd_Smed_v6_11693_0_1, [Score=322, Expect=8e-103]} {RNA1509_19743, RNA1509_48603} {RNA1310_24036, RNA1509_19743, RNA1509_48603} {RNA1509_19743, RNA1509_48603, RNA815_18470} |
| 94. | MligTC455_11579 | 34 | 0.71 | Mlig455_045788 | Neo: - Age: - |
0.988 | - | - | - | 0.988 | - | - | Mlig455_045788 {REF} {Length: 2523} {Pfam: 7 transmembrane receptor (Secretin family) [PF00002.26, score=39.4]} {RNA1509_6409} {RNA1310_984} {RNA815_7594.1} | |
| 95. | MligTC455_44662 | 76 | 1.57 | Mlig455_038241 | Neo: - Age: logFC(26M/2M)=-0.868 |
ANO7 | 0.987 | - | - | - | 0.987 | - | - | Mlig455_038241 {REF} {Length: 3705} {Pfam: Calcium-activated chloride channel [PF04547.14, score=457.8]} {Human: ENSG00000146205, ANO7, anoctamin 7, [Score=572, Expect=0.0]} {Mouse: ENSMUSG00000034107, Ano7, anoctamin 7, [Score=561, Expect=0.0]} {Dmel: FBgn0038721, subdued, [Score=420, Expect=3e-137]} {Celegans: WBGene00010138, anoh-1, Anoctamin, [Score=165, Expect=1e-43]} {Smed: dd_Smed_v6_19189_0_1, dd_Smed_v6_19189_0_1, [Score=659, Expect=0.0]} {RNA1509_46639} {RNA1310_1412.2} {RNA815_15650} |
| 96. | MligTC455_12775 | 11 | 0.23 | Mlig455_004805 | Neo: - Age: - |
0.986 | - | - | - | - | 0.986 | - | Mlig455_004805 {REF} {Length: 996} {NoTransDecoderORF} {RNA1310_49194} | |
| 97. | MligTC455_26463 | 46 | 0.95 | Mlig455_009434 | Neo: - Age: Down-Down-Up |
CLCA1 | 0.986 | - | - | - | 0.986 | - | - | Mlig455_009434 {REF} {Length: 3958} {Pfam: von Willebrand factor type A domain [PF13519.8, score=57.9]; von Willebrand factor type A domain [PF00092.30, score=42.8]; von Willebrand factor type A domain [PF13768.8, score=41.5]; Calcium-activated chloride channel N terminal [PF08434.13, score=31.1]; VWA domain containing CoxE-like protein [PF05762.16, score=22.1]} {Human: ENSG00000016490, CLCA1, chloride channel accessory 1, [Score=149, Expect=3e-36]; ENSG00000016602, CLCA4, chloride channel accessory 4, [Score=147, Expect=1e-35]} {Mouse: ENSMUSG00000068547, Clca4a, chloride channel accessory 4A, [Score=150, Expect=1e-36]; ENSMUSG00000074195, Clca4b, chloride channel accessory 4B, [Score=148, Expect=7e-36]} {Smed: dd_Smed_v6_968_0_1, dd_Smed_v6_968_0_1, [Score=110, Expect=1e-24]} {RNA1509_49943} {RNA1310_21040.1} {RNA815_1871} |
| 98. | MligTC455_27279 | 104 | 2.17 | Mlig455_052989, Mlig455_053048 | Neo: - Age: Up-Down-Up |
ANK2 | 0.983 | - | - | - | 0.983 | - | - | Mlig455_052989 {REF} {Length: 4886} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=154.0]; Ankyrin repeat [PF00023.32, score=133.3]; Ankyrin repeats (many copies) [PF13637.8, score=116.0]; Ankyrin repeat [PF13606.8, score=101.5]; Ankyrin repeats (many copies) [PF13857.8, score=84.2]; Mab-21 protein [PF03281.16, score=24.8]} {Human: ENSG00000145362, ANK2, ankyrin 2, [Score=164, Expect=3e-40]} {Mouse: ENSMUSG00000032826, Ank2, ankyrin 2, brain, [Score=158, Expect=2e-38]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=159, Expect=1e-38]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=149, Expect=8e-36]} {Smed: dd_Smed_v6_10835_0_2, dd_Smed_v6_10835_0_2, [Score=160, Expect=1e-39]} {RNA1509_49840} {RNA1310_24047} {RNA815_2400.1} Mlig455_053048 {REF} {Length: 5337} {Pfam: Mab-21 protein [PF03281.16, score=25.9]} {RNA1509_57692} {RNA1310_3556, RNA1509_57692} {RNA1509_57692, RNA815_2305} |
| 99. | MligTC455_10345 | 30 | 0.63 | Mlig455_018653, Mlig455_018855 | Neo: - Age: - |
0.981 | - | - | - | 0.981 | - | - | Mlig455_018653 {REF} {Length: 1014} Mlig455_018855 {REF} {Length: 1036} |
|
| 100. | MligTC455_30634 | 114 | 2.38 | Mlig455_025888 | Neo: - Age: Up-Down-Up Region-enriched R2: 6.750/0.00140 |
0.979 | - | - | - | 0.979 | - | - | Mlig455_025888 {REF} {Length: 5266} {Pfam: Integrase core domain [PF00665.28, score=50.8]; DDE superfamily endonuclease [PF13358.8, score=22.0]} {Smed: dd_Smed_v6_1574_6_72, dd_Smed_v6_1574_6_72, [Score=149, Expect=3e-41]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_6291.1} |
There are 189 more genes with r >= 0.95